CytoDyn (CYDY) Inventory (2020 - 2022)

CytoDyn (CYDY) posted Inventory of $88.5 million for Q1 2022, down 2.81% on a QoQ basis from $91.1 million in Q4 2021.

CytoDyn (CYDY) Inventory (2020 - 2022) Analysis & Trends

CytoDyn's Inventory history runs 3 years deep, the most recent figure standing at $88.5 million for Q1 2022.

  • Quarterly Inventory changed N/A year-over-year to $88.5 million in Q1 2022, while the trailing twelve-month figure through Feb 2022 was $88.5 million (changed N/A YoY) and the FY2021 annual result came in at $93.5 million, up 388.22% from the prior year.
  • Inventory was $88.5 million for Q1 2022 at CytoDyn, down from $91.1 million in the prior quarter.
  • Across five years, Inventory topped out at $93.5 million in Q2 2021 and bottomed at $19.1 million in Q2 2020.
  • A 3-year average of $77.1 million and a median of $91.1 million in 2021 frame the typical range for Inventory.
  • Peak annual rise in Inventory reached 388.22% in 2021, while the deepest fall reached 388.22% in 2021.
  • CytoDyn's Inventory stood at $19.1 million in 2020, then soared by 375.58% to $91.1 million in 2021, then fell by 2.81% to $88.5 million in 2022.
  • Business Quant data shows CYDY's Inventory at $88.5 million in Q1 2022, $91.1 million in Q4 2021, and $93.4 million in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 681.59 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.77 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 3.10 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 371.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 CytoDyn 267.79 Mn 267.79 Mn - -

Historic Data

Download Data
DateValue
Feb 28, 2022 88.50 Mn
Nov 30, 2021 91.06 Mn
Aug 31, 2021 93.39 Mn
May 31, 2021 93.48 Mn
May 31, 2020 19.15 Mn